The future level of global spending on medicines has implications for healthcare systems and policymakers across developed and emerging economies, and these issues are even more important in light of the ongoing global COVID-19 pandemic. Stakeholders share common goals of improving health outcomes while controlling costs and expanding access to medicines, which is made more challenging with the numerous uncertainties surrounding the progress of the pandemic.
说明:文中文末广告由腾讯配送,内容与本号无关,但您的每次点击都会给平台带来一点微薄收益,能促使我们继续为您提供更好的服务。仅致以诚挚的感谢,祝阅读愉快!
联系客服